Mechanistically miR-9 inhibits the proliferation and promotes the migration of glioma cells by directly targeting cyclic AMP response element-binding protein (CREB) and neurofibromin 1 (NF1), respectively [40,41,42,43]. The gene discussed is NF1; the disease is glioma.